STOCKWATCH
·
Biotechnology
Quarterly Result31 Jan 2026, 12:52 pm

Advanced Enzyme Technologies Approves Unaudited Financial Results for Q3 & Nine Months Ended Dec 31, 2025, and Collaboration for Group Captive Wind Power Plant

AI Summary

Advanced Enzyme Technologies Limited has informed the Exchange about the unaudited financial results for the quarter and nine months ended December 31, 2025. The Board of Directors approved the results in a meeting on January 31, 2026. Additionally, the Board approved a collaboration with a developer for setting up a Group Captive Wind Power Plant through a Special Purpose Vehicle company, and the Company will invest up to 26% equity stake in the proposed SPV as a Captive User for the said electricity power. This decision may lead to not proceeding further with the group captive Solar power project as intimated earlier.

Key Highlights

  • Advanced Enzyme Technologies approved unaudited financial results for Q3 & nine months ended Dec 31, 2025
  • The Board approved collaboration for setting up a Group Captive Wind Power Plant through a Special Purpose Vehicle company
  • Company to invest up to 26% equity stake in the proposed SPV as a Captive User for the said electricity power
  • This decision may lead to not proceeding further with the group captive Solar power project
  • Financial results and other documents uploaded on the company's website for public access
ADVENZYMES
Biotechnology
Advanced Enzyme Technologies Ltd

Price Impact